Current Situation on Antiretroviral Therapy against HIV-1: Limitation and New Leads
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: closed (28 February 2021) | Viewed by 10891
Special Issue Editor
Special Issue Information
Dear Colleague,
Antiretroviral therapy (ART) has dramatically reduced HIV-1-associated morbidity and mortality, and has transformed HIV-1 infection into a manageable chronic condition by suppressing viral replication. However, despite recent patient care improvements, ART still fails to cure HIV-1 infection, due to the inability to counteract the immune defects and metabolic disturbances associated with residual inflammation alongside viral persistence. Indeed, despite viral suppression, patients under ART display residual anatomic viral reservoirs that need to be targeted in the hope of curing HIV-1 infection. Life-long drug administration also results in multiple side-effects in patients, including lipodystrophy and insulin resistance.
Therefore, it is critical to obtain a clear and documented picture of all limitations that are associated with these current treatments, such as metabolic deregulations, molecule toxicity and reservoir persistence, in an attempt to develop new successful therapeutic strategies. Patient care improvements and the elimination of viral reservoirs can themselves be advanced as end goals to live with or to cure HIV-1 infection, respectively. In this Special Issue, we will focus on the existing antiviral therapy, metabolic and molecular deregulations associated with these medications, and novel viral and host cell targets that are considered to improve ART outcomes. We will also discuss the current situation in HIV-1 reservoirs and potential strategies which aim to purge these infected cells in treated patients.
Dr. Julien Van GrevenyngheGuest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ART (anti-retroviral therapy)
- HIV-1
- Metabolic perturbances
- Viral reservoirs
- Cure
- New drug discovery
- Residual inflammation
- Post-treatment controllers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
